Kiortsis Dimitrios N, Tsouli Sofia, Lourida Evangelia S, Xydis Vasilios, Argyropoulou Maria I, Elisaf Moses, Tselepis Alexandros D
Laboratory of Physiology, University of Ioannina, Ioannina, Greece.
Angiology. 2005 Jul-Aug;56(4):451-8. doi: 10.1177/000331970505600413.
Carotid intima media thickness (IMT), represents an important clinical indicator of early atherosclerosis. Human plasma platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme primarily associated with low-density lipoprotein (LDL) while a small proportion of enzymatic activity is also associated with high-density lipoprotein (HDL). Plasma paraoxonase 1 (PON1) is an esterase exclusively associated with HDL. The authors investigated the possible relationship between carotid IMT and the plasma levels of PAF-AH mass and activity as well as the PON1 activity in hyperlipidemic patients. One hundred unrelated patients with primary hyperlipidemia and 67 age-and sex-matched normolipidemic apparently healthy volunteers participated in the study. The PAF-AH activity in total plasma and in HDL-rich plasma (HDL-PAF-AH activity), the plasma PAF-AH mass, and the serum PON1 activities toward paraoxon and phenyl acetate were determined. The plasma PAF-AH mass and activity were higher in hyperlipidemic patients compared to controls, whereas the HDL-PAF-AH activity, as well as the serum PON1 activities were not significantly different between the studied groups. When hyperlipidemic patients were divided into 2 subgroups according to their IMT values (IMT <0.7 mm and IMT > or =0.7 mm) patients with IMT > or =0.7 mm had significantly higher age, and serum triglyceride concentrations, whereas no difference was found in the plasma PAF-AH mass and activity as well as in the HDL-PAF-AH activity between the 2 studied subgroups. The same phenomenon was observed for serum PON1 activities. In a multivariate analysis, only the age was significantly correlated with IMT values (p<0.05). Neither the total plasma PAF-AH mass and activity nor the HDL-PAF-AH activity are associated with early carotid atherosclerosis.
颈动脉内膜中层厚度(IMT)是早期动脉粥样硬化的一项重要临床指标。人血浆血小板活化因子乙酰水解酶(PAF-AH)是一种主要与低密度脂蛋白(LDL)相关的酶,同时一小部分酶活性也与高密度脂蛋白(HDL)相关。血浆对氧磷酶1(PON1)是一种仅与HDL相关的酯酶。作者研究了高脂血症患者颈动脉IMT与PAF-AH质量和活性的血浆水平以及PON1活性之间的可能关系。100名原发性高脂血症的非相关患者和67名年龄及性别匹配的血脂正常的明显健康志愿者参与了该研究。测定了总血浆和富含HDL的血浆中的PAF-AH活性(HDL-PAF-AH活性)、血浆PAF-AH质量以及血清PON1对对氧磷和苯乙酸的活性。与对照组相比,高脂血症患者的血浆PAF-AH质量和活性更高,而研究组之间的HDL-PAF-AH活性以及血清PON1活性无显著差异。当根据IMT值将高脂血症患者分为两个亚组时(IMT<0.7mm和IMT≥0.7mm),IMT≥0.7mm的患者年龄和血清甘油三酯浓度显著更高,而两个研究亚组之间的血浆PAF-AH质量和活性以及HDL-PAF-AH活性没有差异。血清PON1活性也观察到相同现象。在多变量分析中,只有年龄与IMT值显著相关(p<0.05)。总血浆PAF-AH质量和活性以及HDL-PAF-AH活性均与早期颈动脉粥样硬化无关。